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Rapid eye movement sleep behaviour disorder
(R.B.D.) is a relatively new diagnosis, first
described in the mid-1980s.' These case reports
describe two psychiatric outpatients who
presented with typical features of the disorder
and who had an effective response to treatment
with clonazepam. In one instance the patient had
undergoneseveral medicalevaluations, including
a sleep EEG, but without a definite diagnosis
being reached. Both patients were diagnosed on
clinical grounds, and showed apositive response
to clonazepam. In both cases they experienced
recurrence of symptoms of R.B.D. after
discontinuation or dose reduction and improved
again after rechallenge with clonazepam. This
paperhighlights theneedforclinicians tobe alert
to R.B.D., a condition which is responsive to
clonazepam.
CASE REPORTS
Case 1: Aretiredmanualworker, age83, married
with 2 adult children, who lives with his wife,
wasassessedbyaconsultantinoldagepsychiatry
in March, 1999. He had a history of major
depression, noted by his general practitioner to
have begun in October 1998, which had become
more marked, with social withdrawal and
anhedonia. Althoughnoformalratingscales were
used, thepatientreached criteria for adepressive
disorder, without psychotic features (DSM-IV).
He was also found to be suffering from slight
cognitive impairment, marked by constructional
dyspraxia, although his scoring was 29/30 on the
Mini-mental state 3 and 12/12 on the I/O section
of the Clifton Assessment Procedures for the
Elderly.4 Medical history was significant for
ischaemic heart disease, left ventricular
hypertrophy, diverticular disease and
prostatectomywithinguinalherniarepairin 1983.
He had been commenced on citalopram 20mg
dailybyhisgeneralpractitionerinFebruary 1999.
He was continued on citalopram 20mg daily and
admittedtoapsychiatricdayhospitalfortreatment
on 3/3/99. The citalopram dosage was
progressively increased to 30mg daily by mid-
March 1999, then to 40mg daily by 21/5/99 and
finally to 60mg daily by 5/7/99. From about the
middle of March 1999, the patient began to
complain of disturbing nightmares, which were
associatedwithcomplaintsofhisbody"jumping"
atnightwhile asleep, and occasionally offinding
himselfonthefloorwithsomeassociatedbruising
as a result. He was definite that these were new
experiences and stated that the nightmares in
particular were both unusual and frightening.
Theseexperiences didnotappeartobetemporally
related to the initiation ofcitalopram. A CT scan
of the head, showed mild atrophy, especially of
thefrontallobes and asmall lacunarinfarctofthe
leftbasalganglia. A sleepEEG was carriedoutin
June 1999. This showed that the "awake and
early stages ofsleep were within normal limits".
This sleep study was not an overnight study, but
was carried out between 10.00 am and 2.00 pm,
thepatienthavingbeen sleep-deprived from4.00
am on the morning ofthe test. By October, 1999
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the patient's mood was beginning to improve on
citalopram 60mg daily, however his nocturnal
sleep movement disorder continued.
He was clinically diagnosed in January, 2000
with R.B.D. and commenced on clonazepam 500
microgramsnocte. Withinoneweekofincreasing
thedoseto 1mgnoctehis"dreams, sleepactivity",
as described in his clinical record, had
significantly improved. During the following
several months it was noted that decreases in the
clonazepam from 1mg to alowerdosage resulted
in recurrence of R.B.D. symptoms, typified by
recurringinjuriese.g.tohisheadandleftshoulder.
He also commented himself that he would feel
"sore all over on awakening" and that the
nightmares involved a frightening image of
"chasing or fighting with a female" figure. By
May, 2000 thepatient's moodhadbegun to show
signs of relapse, despite claiming compliance
with the citalopram, with recurrence ofagitation
and initial insomnia along with anhedonia.
Accordingly the citalopram was replaced with
mirtazapine 30mg nocte. In September, 2000 his
depression had improved to a sufficient extent to
allow discharge from the day hospital. To date,
the patient has been followed at a psychiatry
outpatient clinic and continues to maintain
improved sleep pattern from clonazepam 1mg
nocte, which he generally complies with despite
ongoing complaints of a slightly sedated
"hungover" feeling in the mornings; this he
attributes to the medication. It is worthwhile
noting that the change from citalopram to
mirtazapine wasnot, initself, associatedwithany
changes in the frequency or intensity of the
nocturnal sleep movement disorder symptoms.
He was not treated at any point with beta
adrenoceptor antagonists, which have known
abilities to alter sleep patterns.
Case 2: A retired manual worker, age 74, living
with his wife, also in her 70s; he was well, from
a psychiatric standpoint, up until February 1999.
At that time he suffered a myocardial infarction
and had a cardiac arrest, from which he was
successfully resuscitated. During the subsequent
hospitalization he suffered from a delirium but
recovered well from the cardiac standpoint. He
was assessed by a consultant psychiatrist for
"possible visual hallucinations or vivid dreams"
at the request of his general practitioner in
February, 2001. The patient gave a history,
confirmed by his wife, of having experienced
sleep disturbance since June 1999. He would
typically have vivid nightmares, which wouldbe
accompanied by "thrashing around" in bed and
frequently falling out of bed. It had got to the
point where his wife had to sleep elsewhere
because she was afraidofsufferingbodily injury.
The patient would typically have nightmares of
being attacked and would awaken, as a result,
usually about two hours after falling asleep,
according to his wife. In his mental state
examination the patient had signs of mild
cognitive impairment with scores of24/30 in his
Folstein MMSE and 10/12 on the CAPE I/O. His
previous medical history was significant for
angina, myocardial infarction, arthritis, distant
history oftraumatic blindness in left eye, distant
history ofroad traffic accident with head trauma
butnolossofconsciousness, 35 yearspreviously.
A clinical diagnosis ofR.B.D. was made and the
patient was prescribedclonazepam at adosage of
1mg nocte. He was subsequently seenforfollow-
upattheoutpatientdepartment, whereitemerged
that he had had a good clinical response to
clonazepam but had found himself feeling
somewhat"groggy" andsedatedonthefollowing
morning. Because of this he discontinued the
clonazepamandquicklynotedarecurrenceofthe
R.B.D. within a week of doing so. The patient
wasrecommencedonclonazepam 1mg nocteand
has noticed a dramatic improvement in his sleep
quality. The resolution ofthe nightmares and the
potentially dangerous thrashing movements,
which was confirmed by his wife, has greatly
improved the quality of his life and that of his
wife also. Of note in this patient's case was the
use of metoprolol 12.5mg bd, in addition to
elantan LA 25mg daily. The use of these
medications was not temporally related to the
onsetoftheR.B.D. symptoms anditwouldappear
unlikely that these symptoms were related to the
use of the beta adrenoceptor antagonist.
DISCUSSION
Schencketal" 2'5 identifiedanddescribed aform
ofacutebehaviouraldisturbanceoccurringduring
the REM phases of sleep, which was associated
with a lack ofthe usual voluntary muscle atonia,
leading to vigorous and unexpected motor
behaviours. This is in contrast tosomnambulism,
and night terrors, which occur during the non-
REM phases of sleep. In R.B.D. the patient
typically develops a progressive sleep disorder
with the abnormal motor behaviours appearing
during the middle or final third of the night, and
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almost never within the first 60-90 minutes after
sleep onset. The motor behaviours are typically
accompanied by the patient experiencing
nightmares involving his orherbeing attacked or
pursued by frightening dream characters. The
patient talks loudly, shouts orjumps out of bed
during sleep, occasionally injuring himself or
othersintheprocess. Onceawakethepatientmay
take several minutes to reorient himselfand may
have visual hallucinations before regaining full
consciousness. These perceptual distortions on
awakening often arise during delta sleep, not
REM sleep.
SchenckandMahowald6reported70consecutive
cases, which showed a marked predominance
among older males with mean age at onset of53.
These findings were mirrored by Olson et al I
who examined 93 consecutive cases, finding a
mean ageatonsetof60.9 years withan 87% male
preponderance. Both case series found a high
incidence (33%-57%) ofneurological disorders,
including Parkinson's disease, dementia without
parkinsonismandmultiplesystematrophy. Recent
research has led to the realization that R.B.D. is
often an early sign of impending
neurodegenerative disease, particularly
conditions involving alpha-synuclein deposition
e.g. Parkinson' s disease and Lewy body
dementia.8' 9This has given rise to thetheory that
R.B.D. results from a decrease in the normal
inhibitory outflow from pontine centres to the
spinal motor neurones during REM sleep,
allowing motor behaviours to emerge. Also
impressive, in these case series, was the high
incidence of injuries to self or to bed partners
which hadbeen sustained (32%-75%) because of
the sleep disorder, which included occasionally
fractures, dislocations and even subdural
haematomas. Chiu et al 10 examined the
occurrence of R.B.D. in a community sample of
1034 Hong Kong residents, aged 70 years and
above,finding anestimatedprevalenceof0.38%.
Of interest, two of these patients had been
hospitalizedforR.B.D. relatedinjurybeforethey
were correctly diagnosed. In the Schenck and
Mahowald series many of the patients had been
suspected initially of having conditions such as
nocturnalepilepsy, obstructive sleepapnoea, and
various psychiatric conditions. (In Case 1 in this
paper, the patient was initially suspected to have
beensufferingfromside-effects toantidepressants
or alternatively from epilepsy.)
Polysomnographic studies show preservation of
the usual distribution andcycling ofsleep stages.
During non-REM sleep periodic and aperiodic
limb twitching is common. The defining
characteristic, on sleep E.E.G., is intermittent
loss of the normal electromyographic atonia
during REM phases. It is important to note here
that polysomnographic abnormalities can exist
without any clinical behavioural effects,'2 and
that there is also some evidence ofthe existence
of long-standing REM sleep prodromes before
the R.B.D. becomes manifest.2 These findings
arenotsurprisinggiventheincreasingevidence 8,9
that R.B.D. may well represent a common
symptomarrayresultingfromavarietyofdiffuse,
progressive, neurodegenerative disorders.
ThetreatmentofchoiceforR.B.D.isclonazepam,
whichhasbeenshowntobepartiallyorcompletely
successful in treatment in up to 87% of patients
who used the drug.7 In some patients with
contraindications to this drug e.g. respiratory
depressionorobstructivesleepapnoea,alternative
interventions suchassafetythebedenvironment 7
my be sufficient. Alternative pharmacological
treatments include desipramine, carbidopa and
clonidine. Therearealsosomecasesreported 10, 11
of positive response to the acetylcholinesterase
inhibitor, donepezil.
Both cases illustrate the clinical features of the
disorder; episodic loss of skeletal muscle atonia
during REM sleep with consequent complex,
ofteninjurious,behaviouraspatientacts outtheir
dreams. These cases also demonstrate the degree
of disturbance of the patient's and/or spouse's
quality of life which can result, the diagnostic
difficulties involved and the ready response to
clonazepam of R.B.D. Both these patients were
typical clinical presentations of R.B.D.; elderly
maleswithevidenceofneurologicaldamagewho
presentwithnew-onsetsleepdisturbancemarked
by the presence of violent nightmares (of being
attacked,threatenedetc)andvigorousgrossmotor
movements, leading to injury or potential injury
toselfortobedpartners. Inthefirstcasedescribed
the patient was referred for a sleep EEG, but this
did not aid in making a diagnosis. The authors
believethatthisisbecausethestudydidnotcover
the full overnight period. Developments in EEG
technology now allowpatients to wear aportable
monitorathomeovernight, in awayanalogous to
a cardiac Holter monitor. This, in conjunction
with the usual EMG monitoring which
accompanies any EEG, should facilitate to an
improved extent the correct diagnosis ofR.B.D,
© The Ulster Medical Society, 2002.
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as it will allow full overnight monitoring of the
patient. This should also be available at most
district general hospitals, rather than requiring
referralto specialisttertiarycarehospitals. These
cases also illustrate the ready response of this
disordertolowdoseclonazepam,rangingbetween
0.25mgand 1mghere, withmarkedimprovement
in the quality of life for the patients and their
spouses. The authors believe that a reasonable
practice would be, in the first instance and on
clinical grounds to make a diagnosis of R.B.D.
and to initiate a trial of clonazepam, with
evaluationofclinicalresponse. Furthertests such
as sleep EEG could be reserved for cases which
do not show a response to the usually effective
doses of clonazepam, or which are atypical in
otherways. This report also describes a potential
difficulty with clonazepam in this age group,
namely an adverse side-effect of sedation which
mayhaveimplicationsforcomplianceandrequire
psychoeducation on the part of the physician
treatingthesepatients. AfinalpointisthatR.B.D.
should always be considered as part of the
differential diagnosis in elderly patients with
nocturnal wandering and falls.
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